Virological markers and immune response in woodchucks WHV chronic carriers, following lamivudine pre-S/S vaccine therapy

被引:0
|
作者
D'Ugo, E.
Orobello, S.
Canitano, A.
Giuseppetti, R.
Palmieri, G.
Argentini, C.
Rapicetta, M.
机构
[1] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viral Hepatitis Unit, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Pathol Anat Chair, Rome, Italy
关键词
D O I
10.1016/S1386-6532(06)80278-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:S90 / S90
页数:1
相关论文
共 43 条
  • [21] Hepatitis B third-generation vaccines: improved response and conventional vaccine non-response - third generation pre-S/S vaccines overcome non-response
    Zuckerman, JN
    JOURNAL OF VIRAL HEPATITIS, 1998, 5 : 13 - 15
  • [22] Sequence analysis of the Pre-S gene in chronic asymptomatic HBV carriers with low-level HBsAg (vol 42, pg 2689, 2018)
    Wang, Tong
    Dai, Yuzhu
    Zhang, Meng
    Cui, Dawei
    Xu, Xujian
    Sun, Changgui
    Cheng, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (03) : 1553 - 1553
  • [23] Use of Pre-S Protein-Containing Hepatitis B Virus Surface Antigens and a Powerful Adjuvant To Develop an Immune Therapy for Chronic Hepatitis B Virus Infection
    Yum, Jung Sun
    Ahn, Byung Cheol
    Jo, Hyun Jin
    Kim, Dong Yeon
    Kim, Ki Hyun
    Kim, Hyo Sun
    Sung, Young Chul
    Yoon, Jaeseung
    Morrey, John
    Moon, Hong Mo
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (02) : 120 - 127
  • [24] Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody (HBsAb) to hepatitis B surface antigen (HBs Ag).
    Wang, YM
    Ng, WC
    Lo, SK
    HEPATOLOGY, 1997, 26 (04) : 743 - 743
  • [25] The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection
    Yalcin, K
    Danis, R
    Degertekin, H
    Alp, N
    Tekes, S
    Budak, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (04) : 330 - 335
  • [26] SERUM PRE-S1-ANTIGEN AND PRE-S2-ANTIGEN AS PROGNOSTIC MARKERS IN INTERFERON THERAPY FOR CHRONIC HEPATITIS-B
    HARUNA, Y
    HAYASHI, N
    YUKI, N
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (07) : 615 - 619
  • [27] Pre-S Deletion Mutants Co-Exist with Wild-Type Virus at Low Viral Replication Stage in Singapore Chronic Hepatitis B Virus Carriers
    Wei Ning Chen
    Chong Jin Oon
    Current Microbiology, 2002, 44 : 145 - 147
  • [28] Pre-S deletion mutants co-exist with wild-type virus at low viral replication stage in Singapore chronic hepatitis B virus carriers
    Chen, WN
    Oon, CJ
    CURRENT MICROBIOLOGY, 2002, 44 (02) : 145 - 147
  • [29] SERUM HEPATITIS-B VIRUS ASSOCIATED POLYMERIZED HUMAN-SERUM ALBUMIN RECEPTOR (HBV-PAR) ACTIVITY AND PRE-S(2) ANTIGEN (PRE-S(2)AG) LEVEL AFTER INTERFERON THERAPY TO CHRONIC ACTIVE HEPATITIS-B
    IKEDA, H
    MATSUURA, K
    IWASAKI, Y
    NOUSO, K
    TAKAGUCHI, K
    YAMADA, G
    TSUJI, T
    HEPATOLOGY, 1988, 8 (05) : 1426 - 1426
  • [30] Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
    Kanto, Tatsuya
    Inoue, Michiyo
    Oze, Tsugiko
    Miyazaki, Masanori
    Sakakibara, Mitsuru
    Kakita, Naruyasu
    Matsubara, Tokuhiro
    Higashitani, Koyo
    Hagiwara, Hideki
    Iio, Sadaharu
    Katayama, Kazuhiro
    Mita, Eiji
    Kasahara, Akinori
    Hiramatsu, Naoki
    Takehara, Tetsuo
    Hayashi, Norio
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (02) : 169 - 178